SI-BONE (NASDAQ:SIBN – Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.26) by $0.04, Yahoo Finance reports. The firm had revenue of $39.97 million during the quarter, compared to analysts’ expectations of $38.95 million. SI-BONE had a negative net margin of 29.93% and a negative return on equity of 25.14%. During the same period last year, the business earned ($0.30) earnings per share.
SI-BONE Trading Down 0.7 %
Shares of NASDAQ SIBN traded down $0.10 during trading on Wednesday, reaching $14.12. The stock had a trading volume of 419,450 shares, compared to its average volume of 406,873. The company has a debt-to-equity ratio of 0.22, a quick ratio of 8.75 and a current ratio of 9.76. The company has a market cap of $581.89 million, a P/E ratio of -12.93 and a beta of 1.20. SI-BONE has a fifty-two week low of $11.76 and a fifty-two week high of $23.81. The business’s 50-day moving average price is $14.05 and its 200-day moving average price is $15.92.
Insider Activity at SI-BONE
In other news, insider Anthony J. Recupero sold 3,941 shares of the stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $15.10, for a total transaction of $59,509.10. Following the sale, the insider now owns 247,592 shares of the company’s stock, valued at $3,738,639.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other SI-BONE news, insider Anthony J. Recupero sold 3,941 shares of the business’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $15.10, for a total value of $59,509.10. Following the completion of the transaction, the insider now owns 247,592 shares in the company, valued at $3,738,639.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Anshul Maheshwari sold 2,441 shares of the stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $15.14, for a total value of $36,956.74. Following the completion of the sale, the chief financial officer now owns 204,241 shares in the company, valued at $3,092,208.74. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 11,956 shares of company stock worth $172,480. 5.40% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
Get Our Latest Analysis on SI-BONE
SI-BONE Company Profile
SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.
Featured Articles
- Five stocks we like better than SI-BONE
- Are Penny Stocks a Good Fit for Your Portfolio?
- What Are Bonds? A High-Level Overview
- What is a Stock Market Index and How Do You Use Them?
- Super Micro Stock Drops Sharply After Earnings on Margin Concerns
- 10 Best Airline Stocks to Buy
- Lyft’s First-Ever Profit, but the Outlook Is a Speed Bump
Receive News & Ratings for SI-BONE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SI-BONE and related companies with MarketBeat.com's FREE daily email newsletter.